Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 1
2024 4
2025 7
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Understanding European patterns of deprescribing antithrombotic medication during end-of-life care in patients with cancer.
Martens ESL, Becker D, Abele C, Abbel D, Achterberg WP, Bax JJ, Bertoletti L, Edwards ME, Font C, Gava A, Goedegebuur J, Højen AA, Huisman MV, Kruip MJHA, Mahé I, Mooijaart SP, Pearson M, Seddon K, Szmit S, Noble SIR, Klok FA, Konstantinides SV. Martens ESL, et al. Among authors: goedegebuur j. Thromb Res. 2025 Jan;245:109205. doi: 10.1016/j.thromres.2024.109205. Epub 2024 Nov 9. Thromb Res. 2025. PMID: 39667100 Free article.
Use of antithrombotic therapy and the risk of cardiovascular outcomes and bleeding in cancer patients at the end of life: a Danish nationwide cohort study.
Søgaard M, Ørskov M, Jensen M, Goedegebuur J, Kempers EK, Visser C, Geijteman ECT, Abbel D, Mooijaart SP, Geersing GJ, Portielje J, Edwards A, Aldridge SJ, Akbari A, Højen AA, Klok FA, Noble S, Cannegieter S, Ording AG. Søgaard M, et al. Among authors: goedegebuur j. J Thromb Haemost. 2025 Jan;23(1):190-200. doi: 10.1016/j.jtha.2024.09.023. Epub 2024 Oct 10. J Thromb Haemost. 2025. PMID: 39393778 Free article.
Anti-thrombotic therapy in patients with cancer at the end of life: A cohort study using population-linked routinely collected data.
Aldridge SJ, Akbari A, Edwards A, Lifford KJ, Abbel D, Cannegieter S, Goedegebuur J, Kempers EK, Søgaard M, Visser C, Geersing GJ, Kruip MJH, Ording AG, van den Dries C, Geijteman ECT, Klok FA, Mahé I, Mooijaart SP, Szmit S, Noble S. Aldridge SJ, et al. Among authors: goedegebuur j. Br J Haematol. 2025 Nov;207(5):2080-2090. doi: 10.1111/bjh.70032. Epub 2025 Sep 1. Br J Haematol. 2025. PMID: 40890090 Free PMC article.
Discontinuation of Anticoagulants and Occurrence of Bleeding and Thromboembolic Events in Vitamin K Antagonist Users with a Life-limiting Disease.
Kempers EK, Visser C, Geijteman ECT, Goedegebuur J, Portielje JEA, Søgaard M, Ording AG, van den Dries C, Abbel D, Geersing GJ, Aldridge SJ, Lifford KJ, Akbari A, van de Leur SJCM, Nierman MC, Mahé I, Mooijaart SP, Szmit S, Edwards M, Noble SIR, Klok FA, Chen Q, Cannegieter SC, Kruip MJHA; SERENITY consortium. Kempers EK, et al. Among authors: goedegebuur j. Thromb Haemost. 2025 Apr 4. doi: 10.1055/a-2524-5334. Online ahead of print. Thromb Haemost. 2025. PMID: 39855271 Free article.
Determining Drug Exposure Based on Medication Dispensing Data: A Validation Study of Vitamin K Antagonist Treatment Episodes Against INR Records.
Kempers EK, Visser C, Goedegebuur J, Chen Q, Søgaard M, Ording AG, van den Dries C, Abbel D, Aldridge SJ, Lifford KJ, Portielje JEA, Nierman MC, Boetes-Draisma A, van de Leur SJCM, Klok FA, Geijteman ECT, Kruip MJHA, Cannegieter SC. Kempers EK, et al. Among authors: goedegebuur j. Pharmacoepidemiol Drug Saf. 2025 Jun;34(6):e70158. doi: 10.1002/pds.70158. Pharmacoepidemiol Drug Saf. 2025. PMID: 40389391 Free PMC article.
Towards optimal use of antithrombotic therapy of people with cancer at the end of life: A research protocol for the development and implementation of the SERENITY shared decision support tool.
Goedegebuur J, Abbel D, Accassat S, Achterberg WP, Akbari A, Arfuch VM, Baddeley E, Bax JJ, Becker D, Bergmeijer B, Bertoletti L, Blom JW, Calvetti A, Cannegieter SC, Castro L, Chavannes NH, Coma-Auli N, Couffignal C, Edwards A, Edwards M, Enggaard H, Font C, Gava A, Geersing GJ, Geijteman ECT, Greenley S, Gregory C, Gussekloo J, Hoffmann I, Højen AA, van den Hout WB, Huisman MV, Jacobsen S, Jagosh J, Johnson MJ, Jørgensen L, Juffermans CCM, Kempers EK, Konstantinides S, Kroder AF, Kruip MJHA, Lafaie L, Langendoen JW, Larsen TB, Lifford K, van der Linden YM, Mahé I, Maiorana L, Maraveyas A, Martens ESL, Mayeur D, van Mens TE, Mohr K, Mooijaart SP, Murtagh FEM, Nelson A, Nielsen PB, Ording AG, Ørskov M, Pearson M, Poenou G, Portielje JEA, Raczkiewicz D, Rasmussen K, Trinks-Roerdink E, Schippers I, Seddon K, Sexton K, Sivell S, Skjøth F, Søgaard M, Szmit S, Trompet S, Vassal P, Visser C, van Vliet LM, Wilson E, Klok FA, Noble SIR. Goedegebuur J, et al. Thromb Res. 2023 Aug;228:54-60. doi: 10.1016/j.thromres.2023.05.008. Epub 2023 May 13. Thromb Res. 2023. PMID: 37276718 Free article.
Phosphodiesterase 3 inhibitors do not influence lactate kinetics and clinical outcomes in patients with septic shock: A multicentre cohort study.
Tai-Passmann S, Slegers CAD, Hemelaar P, Waalders N, Koopmans M, van den Bogaard B, van Lookeren Campagne M, Goedegebuur J, Kuindersma M, Schroten N, van der Elsen F, Grady BPX, van den Beuken WMF, Kiers D, Pickkers P, van den Oever HLA; Research Collaboration Critical Care Netherlands (RCCNet), Piladys (PDE3i and lactate dynamics in septic shock) working group. Tai-Passmann S, et al. Among authors: goedegebuur j. J Crit Care. 2024 Oct;83:154827. doi: 10.1016/j.jcrc.2024.154827. Epub 2024 May 7. J Crit Care. 2024. PMID: 38718462
11 results